ImClone’s Icahn Calls Bristol-Myers’s Hostile Bid ‘Absurd’

In the latest installment of a long-running correspondence, Icahn rejects the latest Bristol offer as inadequate and tells the company's CEO there are more productive ways to make lawyers wealthier.